Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients.
Ken KuduraFlorentia DimitriouDaniela Mihic-ProbstUrs J MuehlematterTim KutzkerLucas BaslerRobert FoersterReinhard DummerJoanna ManganaLars HusmannIrene A BurgerMichael Christoph KreisslPublished in: Diagnostics (Basel, Switzerland) (2021)
Indeterminate findings on FDG-PET/CT in metastatic cutaneous melanoma patients should be further investigated. Almost one out of every two indeterminate findings on FDG-PET/CT is malignant. The majority of the findings are melanoma manifestations, however, in a significant percentage, other primary tumors are found. Upon verification, patient management is changed in most cases.